DAEJEON, South Korea--(BUSINESS WIRE)--Established in 1976, the Electronics and Telecommunications Research Institute (ETRI) in Daejeon, South Korea, is the government-sponsored R&D institute in the area of information, communications, electronics, broadcasting, and convergence technologies. Over 2,600 researchers and staff members are hard at work contributing to the growth of Korea�s economy.

Today, ETRI is focusing on AI-driven technologies. According to the 2019 WIPO Technology Trends Report, ETRI ranked 2nd globally in AI patent applications among top universities and public organizations. (www.wipo.int/wipo_magazine/en/2019/01/article_0001.html)

ETRI is actively involved in strategic technology licensing to move research innovations to public market. ETRI Holdings and ETRI�s internal technology licensing office (TLO) collaborate to incubate startups using ETRI technology until they are ready for IPO or M&A. Successful startup investments include Optella Inc. (https://www.cosemi.com/optella/), Syntekabio (www.syntekabio.com/eng/), Sugentech (www.sugentech.com/main.php), Genesystem (www.genesystem.co.kr/), and Minds Lab (mindslab.ai:8080/en).

To foster global collaboration, ETRI�s USA R&D center in Silicon Valley is actively seeking partnerships between Korea and leading players in the US. ETRI plans to present recent research and TLO activities in the US-Korea Conference (UKC2021, ukc.ksea.org/ukc2021/), which will be held December 15 � 18, 2021, in Garden Grove, near Los Angeles, California.

For more information about ETRI, please visit www.etri.re.kr/eng/main/main.etri.

Contacts

Partnership and R&D inquiries please contact

Dr. Jie Hyun Lee, ETRI USA R&D Center, Director General, Email: [email protected]